Acella Pharmaceuticals, LLC, Announces Appointment Of New Chief Executive Officer

ATLANTA, April 8, 2016 /PRNewswire/ -- Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, is pleased to announce the appointment of Mr. Harold. A Deas, Jr. as Chief Executive Officer. Mr. Deas, who will retain his role as Chief Operating Officer, has been instrumental in helping Acella build a successful portfolio of generic and specialty, niche pharmaceutical drug and medical device products. Mr. Deas will be driving corporate expansion while identifying strategic opportunities within the markets core to the company's business. 

"Acella is an important niche company," said Mr. Deas.  "It fills an essential role in the marketplace. I am pleased to be a part of Acella's continued success, and to meeting the changing needs of our customers and industry." 

About Acella Pharmaceuticals, LLC

Acella develops markets, sells and distributes a broad portfolio of non-branded pharmaceutical and other products in the areas of Dermatology, Women's Health, Pediatrics and other applications. Acella specializes in identifying and bringing to market quality, affordable products to customers and patients.  For additional information please contact Acella at 678-325-5189.

Logo - http://photos.prnewswire.com/prnh/20160407/352847LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/acella-pharmaceuticals-llc-announces-appointment-of-new-chief-executive-officer-300248133.html

SOURCE Acella Pharmaceuticals, LLC